Loading your page…
Preprints.org
By Nakao M, Fukuzawa M, Sunamura M and 14 others.
/Objectives: Gastric cancer (GC) is one of the most prevalent malignancies worldwide, highlighting the need for minimally invasive and highly accurate screening methods for its early detection. We evaluated the utility of salivary polyamine-based metabolomic analysis for distinguishing individuals with GC from those without GC.
Ward brings these articles into the same app as your cards and questions. One free account for Ward, Suture, Osler and Prognia.
A total of 53 patients with GC and 37 non-GC controls were included. Participants were recruited from individuals who underwent upper gastrointestinal endoscopy at Tokyo Medical University Hospital between March 2020 and May 2025 and provided saliva samples on the same day. Participants with factors known to affect polyamine levels were excluded. Salivary metabolites quantified by liquid chromatography–mass spectrometry were statistically compared between groups. Acetylated-to-non-acetylated polyamine ratios were used as features to construct a logistic regression-based machine learning model, and discriminative performance was evaluated using receiver operating characteristic analysis.
The GC group showed significantly higher concentrations of salivary metabolites. Among individual polyamines, N1-acetylspermine demonstrated the highest discriminative ability (AUC = 0.845). When acetylated-to-non-acetylated polyamine ratios were analyzed, significant differences between groups were observed for N1,N8-diacetylspermidine/spermidine and N1-acetylspermine/spermine. A logistic regression model constructed using six such ratios achieved strong predictive performance in the test dataset (AUC = 0.807), with a sensitivity of 81.3% and a specificity of 72.7%. Notably, these ratios outperformed conventional tumor markers such as carcinoembryonic antigen and carbohydrate antigen 19-9, in sensitivity.
Our results demonstrate that salivary polyamine analysis, particularly using acetylation ratios, enables accurate and minimally invasive detection of GC and represents a promising adjunctive tool for GC screening.
This is a preprint: it has not been peer reviewed yet, and its findings may change.
Published in Preprints.org (preprint). The abstract is shown as published and remains the work of its authors; read the full article at the source.
Prognia lists this article for reference and education. It is not medical advice. Always read the original and follow current guidelines and local protocols before acting on it.
